InfuSystem Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Revenue (Tables)

3 Months Ended

Mar. 31, 2026

The following table presents the Company’s disaggregated revenue by offering type (in thousands):


	Three Months Ended March 31,
	2026				2025
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	673	2.0	%	$	638	1.8	%
Third-Party Payer products	4,868		14.5	%	3,951		11.4	%
Patient Services revenue recognized over time:
Direct rental services	1,963		5.8	%	1,914		5.5	%
Third-Party Payer rental services	12,484		37.1	%	12,215		35.2	%
Total Patient Services accounted for under ASC 606	19,988		59.3	%	18,718		53.9	%
Device Solutions revenue recognized at a point in time:
Products	3,335		9.9	%	4,002		11.5	%
Services	2,792		8.3	%	2,350		6.8	%
Device Solutions revenue recognized over time:
Services	149		0.4	%	1,855		5.3	%
Total Device Solutions accounted for under ASC 606	6,276		18.6	%	8,207		23.6	%
Total Revenue Accounted for under ASC 606	26,264		78.0	%	26,925		77.6	%
Patient Services lease revenue	2,117		6.3	%	2,056		5.9	%
Device Solutions lease revenue	5,303		15.7	%	5,735		16.5	%
Total Revenue accounted for under ASC 842, Leases	7,420		22.0	%	7,791		22.4	%
Total Net Revenue	$	33,684	100.0	%	$	34,716	100.0	%